GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vext Science Inc (OTCPK:VEXTF) » Definitions » Capex-to-Revenue

VEXTF (Vext Science) Capex-to-Revenue : 0.00 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Vext Science Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Vext Science's Capital Expenditure for the three months ended in Sep. 2024 was $-0.02 Mil. Its Revenue for the three months ended in Sep. 2024 was $8.99 Mil.

Hence, Vext Science's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.00.


Vext Science Capex-to-Revenue Historical Data

The historical data trend for Vext Science's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vext Science Capex-to-Revenue Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial 0.24 0.16 0.50 0.25 0.08

Vext Science Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.11 0.01 0.07 -

Competitive Comparison of Vext Science's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vext Science's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vext Science's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Vext Science's Capex-to-Revenue falls into.



Vext Science Capex-to-Revenue Calculation

Vext Science's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.737) / 34.812
=0.08

Vext Science's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.015) / 8.987
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vext Science  (OTCPK:VEXTF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Vext Science Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vext Science's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Vext Science Business Description

Traded in Other Exchanges
Address
4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The Company's operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.